Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer
W M Stadler, T Kuzel, B Roth, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 1999
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
M Chien, M Astumian, D Liebowitz, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer
W M Stadler, N J Vogelzang, E E Vokes, et al.
Investigational New Drugs
|
September 20, 2001
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer
N J Vogelzang, M Aklilu, W M Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
W M Stadler, T Kuzel, C Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization
W M Stadler, G Steinberg, X Yang, et al.
Cancer
|
March 16, 2000
Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials
C W Ryan, N J Vogelzang, M C Dumas, et al.
The Journal of Urology
|
March 21, 2001
Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma
B I Rini, T M Zimmerman, T F Gajewski, et al.
Technology in Cancer Research & Treatment
|
August 22, 2012
Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis
C R Haney, X Fan, E Markiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2000
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea
F Innocenti, W M Stadler, L Iyer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer
W M Stadler, T Kuzel, B Roth, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 1999
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
M Chien, M Astumian, D Liebowitz, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer
W M Stadler, N J Vogelzang, E E Vokes, et al.
Investigational New Drugs
|
September 20, 2001
A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer
N J Vogelzang, M Aklilu, W M Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
W M Stadler, T Kuzel, C Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization
W M Stadler, G Steinberg, X Yang, et al.
Cancer
|
March 16, 2000
Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials
C W Ryan, N J Vogelzang, M C Dumas, et al.
The Journal of Urology
|
March 21, 2001
Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma
B I Rini, T M Zimmerman, T F Gajewski, et al.
Technology in Cancer Research & Treatment
|
August 22, 2012
Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis
C R Haney, X Fan, E Markiewicz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2000
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea
F Innocenti, W M Stadler, L Iyer, et al.
Page
of 7